J. Saluja

发表

Lower tumor mutational burden (TMB) and hepatic metastases may predict for lack of response to PD-1 blockade in MSI-H metastatic colorectal cancer (MCRC).

M. Fakih, S. Rahmanuddin, A. Schrock, 2018, Annals of oncology : official journal of the European Society for Medical Oncology.

Regorafenib and Nivolumab or Pembrolizumab Combination and Circulating Tumor DNA Response Assessment in Refractory Microsatellite Stable Colorectal Cancer

M. Fakih, Chongkai Wang, J. Sandhu, 2020, The oncologist.